Every Form 4 that Atlanta Braves Holdings, Inc. Series A (BATRA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BATRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BATRA filings page.
Atlanta Braves Holdings, Inc. (BATRA/BATRK) reported insider transactions by Jill L. Robinson, EVP, CFO & Treasurer. On August 19, 2026, she exercised options for 30,263 shares of Series C Common Stock at an exercise price of $27.18 per share and then sold 30,263 shares at a weighted average price of $52.84 per share, under a Rule 10b5-1 sales plan adopted on May 18, 2026.
Atlanta Braves Holdings, Inc. insider group GAMCO-related reporting persons disclosed activity in Series A Common Stock. The filing shows an open-market sale of 500 shares on March 2, 2026 at $48.20 per share, leaving 11,500 shares in that direct account. Additional lines list direct and indirect holdings totaling 42,000, 27,152, and 15,000, 12,500, 20,000, and 2,800 shares held through various investment partnerships. Footnotes state that certain positions are owned by Associated Capital Group, Inc., GGCP, Inc., and Mario J. Gabelli, and clarify that the securities reported exceed the reporting persons’ indirect pecuniary interests, which they disclaim beyond their actual economic stake.
Atlanta Braves Holdings, Inc. insider John C. Malone, a ten percent owner, rebalanced his holdings between share classes in a private, related-party exchange on February 25, 2026. He acquired 10,868 shares of Series B Common Stock from two trusts whose beneficiaries are his adult children. In return, he contributed an aggregate 14,614 shares of Series C Common Stock and $42.18 in cash to those trusts.
Following these transactions, Malone directly held 14,537 shares of Series B Common Stock and 2,662,534 shares of Series C Common Stock. He also reported additional indirect holdings of Series B and Series C shares through entities including JCM AB LLC, the John C. Malone June 2003 Charitable Remainder Unitrust, and the Leslie A. Malone 1995 Revocable Trust.
Atlanta Braves Holdings, Inc. executive Jill L. Robinson, EVP, CFO & Treasurer, exercised options for 60,000 shares of Series C Common Stock at a stated exercise price of $0.0000 per share and acquired the underlying stock at $27.1800 per share. She then sold 60,000 Series C shares on the same day at $42.0000 per share in an open-market transaction.
After these transactions, she directly owned 79,460 Series C Common shares and 30,263 stock options. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025.
John C. Malone, a 10% owner of Atlanta Braves Holdings, Inc., reported open-market-like purchases of the company’s common stock. On February 5, 2026, he acquired 35,000 shares of Series A Common Stock at a weighted average price of $44.23, bringing his direct Series A holdings to 521,862 shares. On February 4, 2026, he purchased 3,669 shares of Series B Common Stock in a private transaction at $48.17, and now directly holds 3,669 Series B shares. He also has indirect exposure through entities: 887,079 Series B shares are held by JCM AB LLC, and 10,177 Series A and 47,585 Series B shares are held by the Leslie A. Malone 1995 Revocable Trust, for which he disclaims beneficial ownership.
Atlanta Braves Holdings executive Jill L. Robinson exercised stock options and sold shares of Series C Common Stock. On 02/02/2026, she exercised options for 20,000 BATRK shares at an exercise price of $27.18 per share and received 20,000 shares.
That same day, she sold 20,000 Series C Common shares at a weighted average price of $40.00 per share, within a range of $39.71 to $40.22, under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025. After these transactions, she directly owned 79,460 Series C Common shares and held 90,263 stock options.
Atlanta Braves Holdings, Inc.'s EVP, CLO & Secretary reported vesting of restricted stock units and a related share sale in Series C common stock.
On December 11, 2025, 7,660 restricted stock units converted into 7,660 shares of Series C common stock at $0, resulting in 30,164 shares directly owned. On December 12, 2025, the officer sold 7,423 shares at a weighted average price of $39.71, in part to cover tax withholding obligations, and afterward held 22,741 Series C shares and 7,661 restricted stock units.
Atlanta Braves Holdings, Inc. executive vice president of development reported equity award activity involving Series C Common Stock (BATRK). On December 11, 2025, 11,142 restricted stock units converted into an equal number of shares at $0, bringing direct holdings to 250,467 shares. On December 12, 2025, 4,874 shares were sold at a weighted average price of $39.74 to cover tax withholding tied to the vesting, leaving 245,593 shares held directly. The report also notes 55,503 shares held indirectly through a grantor retained annuity trust and 11,142 restricted stock units outstanding, with the remaining units scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. reported that its EVP, CFO & Treasurer converted 7,660 restricted stock units into Series C Common Stock on December 11, 2025, at an exercise price of $0 per share. On December 12, 2025, the executive sold 3,830 Series C shares in an open-market transaction coded as a sale, at a weighted average price of $39.70.
The sale was carried out under a Rule 10b5-1 sales plan adopted on May 15, 2025 and was intended to cover tax withholding obligations tied to the RSU vesting. The price range for the sale was from $39.37 to $40.12. After these transactions, the executive directly held 79,460 Series C shares, and the remaining restricted stock units continue vesting in tranches, with the final portion scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. reported insider activity by its EVP, Business. On December 11, 2025, restricted stock units converted into 11,142 shares of Series C Common Stock at an exercise price of $0, increasing the officer's direct holdings to 321,782 shares.
On December 12, 2025, the officer sold 4,874 shares at a weighted average price of $39.73, within a range of $39.37 to $40.12, to cover tax withholding obligations related to the RSU vesting. After these transactions, the officer directly owns 316,908 shares of Series C Common Stock and holds 11,142 restricted stock units, with the remaining units scheduled to vest on December 11, 2026.
A senior insider of Atlanta Braves Holdings, Inc. who serves as chairman, president and CEO and a 10% owner reported equity award activity in Series C common stock.
On December 11, 2025, 15,042 restricted stock units converted into the same number of Series C shares at $0. On December 12, 2025, 6,688 shares were sold at a weighted average price of $39.72 to cover tax withholding, leaving 248,695 Series C shares held directly.
An additional 265,000 Series C shares are held indirectly through a trust. The restricted stock units vest in three equal installments on December 11, 2024, 2025 and 2026.
Atlanta Braves Holdings, Inc. reported equity transactions by a company executive serving as EVP, Chief People & Culture Officer. On December 11, 2025, 1,880 restricted stock units converted into an equal number of Series C Common Stock shares at $0 per share. On December 12, 2025, 826 Series C shares were sold at a weighted average price of $39.71 to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
Following these transactions, the executive directly owned 6,040 Series C Common Stock shares and 1,881 remaining restricted stock units. The RSU award vests in three equal installments, with one-third having vested on December 11, 2024 and 2025, and the final third scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. (BATRA) reported an insider stock purchase by a company director on 11/19/2025. The director bought 2,259 shares of Series A Common Stock at a price of $42 per share, increasing the director's directly held position to 486,862 shares. In addition, 10,177 shares are held indirectly through the Leslie A. Malone 1995 Revocable Trust, for which the reporting person disclaims beneficial ownership.
Atlanta Braves Holdings, Inc. (BATRA) reported insider share purchases by a director and 10% owner. On 11/17/2025, the reporting person bought 28,567 shares of Series A common stock in open market transactions at a weighted average price of $41.97 per share, with individual trades ranging from $41.93 to $42.00. On 11/18/2025, they bought an additional 4,631 Series A shares at a weighted average price of $41.99 per share, with trade prices ranging from $41.96 to $42.00.
After these transactions, the reporting person directly owned 484,603 shares of Series A common stock. The form also shows 10,177 shares held indirectly through the Leslie A. Malone 1995 Revocable Trust, for which the reporting person disclaims beneficial ownership. The purchases were reported on Form 4 as required for insiders of the company.
Atlanta Braves Holdings, Inc. (BATRA) reported insider share purchases by a company director. The reporting person bought 1,600 shares of Series A common stock on 11/13/2025 at a weighted average price of $41.993 and a further 18,787 shares on 11/14/2025 at a weighted average price of $41.97, both through open-market transactions. After these purchases, the reporting person directly beneficially owned 451,405 Series A shares and indirectly held 10,177 shares through the Leslie A. Malone 1995 Revocable Trust, for which beneficial ownership is disclaimed. The price ranges for the reported trades were $41.97 to $42.00 on 11/13/2025 and $41.88 to $42.00 on 11/14/2025.
Atlanta Braves Holdings, Inc. (BATRA) filed a Form 4 showing a director’s open‑market purchase. On 11/10/2025, the reporting person bought 3,840 shares of Series A Common Stock at a weighted average price of $41.988, with trade prices ranging from $41.92 to $42.00. Following the transaction, the reporting person beneficially owns 431,018 shares directly. An additional 10,177 shares are listed as indirectly held through the Leslie A. Malone 1995 Revocable Trust, with beneficial ownership disclaimed.
Atlanta Braves Holdings, Inc. (BATRA) reported insider open‑market purchases by a director. The insider bought 31,431 Series A shares on 11/06/2025 at a weighted average price of $41.95 and 23,200 shares on 11/07/2025 at a weighted average price of $41.958.
Following these transactions, direct holdings rose to 427,178 shares. An additional 10,177 shares are reported as indirectly held through the Leslie A. Malone 1995 Revocable Trust, with beneficial ownership disclaimed. The filing notes the trades were aggregated and provides disclosed price ranges of $41.85–$42.00 and $41.76–$42.00.
Atlanta Braves Holdings (BATRA) disclosed an insider transaction on a Form 4. A director reported an open‑market purchase (code P) of 840 shares of Series A Common Stock on 10/27/2025 at a weighted average price of $41.994, with trade prices ranging from $41.97 to $42.00.
Following the transaction, the reporting person beneficially owned 372,547 shares directly and 10,177 shares indirectly via the Leslie A. Malone 1995 Revocable Trust. The reporting person disclaims beneficial ownership of the indirectly held shares.
Atlanta Braves Holdings insider Jill L. Robinson, who is listed as EVP, CFO & Treasurer, executed two related transactions on 10/01/2025. She exercised a stock option to acquire 20,000 Series C common shares at an exercise price of $27.18, and on the same day sold 20,000 Series C common shares under a Rule 10b5-1 sales plan adopted May 15, 2025, at a weighted-average sale price of $40.998 (reported range $40.81–$41.18. After the transactions the filings show 68,755 Series C shares owned directly and 130,263 total Series C shares beneficially owned as reported in the derivative table.